ArticleStem cell research & therapy2025
Cx43 hemichannel-mediated paracrine involves in the promotion of MSCs on skin wound healing.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMesenchymal stem cells (MSCs) exhibit therapeutic potential in wound healing, primarily through their paracrine effects. However, the specific mechanisms underlying these effects remain ambiguous. Connexin 43 (Cx43), the most abundantly expressed connexins in MSCs, forms hemichannels that mediate the paracrine release of small molecules, suggesting a potential role in MSC-mediated wound healing.
methodsA full-thickness skin wound model was established in mice to investigate the role of Cx43 hemichannels in MSC-mediated wound healing. Wounds were treated with MSC-conditioned medium (MSC CM), Cx43 hemichannel-inhibited medium (18α-GA CM), or control medium (CTRL CM, complete medium). The assessment of wound healing was conducted through histological and immunofluorescence analyses. Besides, macrophages, endothelial cells, and fibroblasts treated with the three media were subjected to in vitro investigations. The underlying mechanisms were investigated using qRT-PCR, Western blotting, and immunofluorescence.
resultsMSC CM promoted wound healing partly through Cx43-dependent mechanisms. Cx43 hemichannel-dependent ATP release activated purinergic receptors and the AKT signaling pathway to facilitate macrophage polarization during the inflammatory phase of wound healing. Inhibition of Cx43 hemichannels prevented MSC CM-induced angiogenesis activation and fibroblast migration during the proliferation phase.
conclusionsOur findings reveal a novel mechanism that MSCs promote wound healing through Cx43 hemichannel-mediated paracrine, mainly ATP secretion. MSC CM facilitates macrophage polarization, angiogenesis, and fibroblast migration, ultimately enhancing tissue repair. Our finding identifies a novel role for Cx43 hemichannels in the process that MSCs facilitate tissue repair and offer a promising therapeutic strategy in clinical applications to improve wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.